Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
RARE on Nasdaq
Emil D. Kakkis - trading volume in the past year for Ultragenyx Pharmaceutical Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2.16M |
$91.7M |
$42.48 |
Feb 28, 2025 |
By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 |
|
|
| Common Stock |
642K |
$27M |
$42.10 |
Mar 3, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
78.4K |
|
|
Mar 1, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.